Novartis CEO on Acquisitions, AI, Weight-Loss Drugs
David Rubenstein David Rubenstein
251K subscribers
18,230 views
0

 Published On Feb 16, 2024

Novartis CEO Vas Narasimhan talks about acquisitions, AI and the future of weight-loss drugs. He speaks on "The David Rubenstein Show: Peer-to-Peer Conversations." This interview was recorded Feb. 15 in New York.

show more

Share/Embed